123 related articles for article (PubMed ID: 14667272)
21. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
Pepe C; Hasan B; Winton TL; Seymour L; Graham B; Livingston RB; Johnson DH; Rigas JR; Ding K; Shepherd FA;
J Clin Oncol; 2007 Apr; 25(12):1553-61. PubMed ID: 17442999
[TBL] [Abstract][Full Text] [Related]
22. Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients.
Rossi A; Maione P; Gridelli C
Expert Opin Drug Saf; 2005 Nov; 4(6):1051-67. PubMed ID: 16255664
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.
Okamoto I; Moriyama E; Fujii S; Kishi H; Nomura M; Goto E; Kiyofuji C; Imamura F; Mori T; Matsumoto M
Jpn J Clin Oncol; 2005 Apr; 35(4):188-94. PubMed ID: 15845567
[TBL] [Abstract][Full Text] [Related]
24. The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.
Hensing TA; Peterman AH; Schell MJ; Lee JH; Socinski MA
Cancer; 2003 Aug; 98(4):779-88. PubMed ID: 12910523
[TBL] [Abstract][Full Text] [Related]
25. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
26. Non-small cell lung cancer therapy in the elderly.
Gridelli C; Rossi A; Maione P; Schettino C; Bareschino MA; Palazzolo G; Zeppa R; Ambrosio R; Barbato V; Sacco PC
Clin Adv Hematol Oncol; 2011 May; 9(5):375-83. PubMed ID: 21685866
[TBL] [Abstract][Full Text] [Related]
27. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
[TBL] [Abstract][Full Text] [Related]
28. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).
Lilenbaum RC; Herndon JE; List MA; Desch C; Watson DM; Miller AA; Graziano SL; Perry MC; Saville W; Chahinian P; Weeks JC; Holland JC; Green MR
J Clin Oncol; 2005 Jan; 23(1):190-6. PubMed ID: 15625373
[TBL] [Abstract][Full Text] [Related]
29. Treatment of advanced lung cancer in the elderly.
Gajra A; Lichtman SM
Hosp Pract (1995); 2011 Apr; 39(2):107-15. PubMed ID: 21576903
[TBL] [Abstract][Full Text] [Related]
30. Treatment of non-small-cell lung cancer in older persons.
Basche M; Kelly K
Oncology (Williston Park); 2003 Jan; 17(1):31-9; discussion 43-4, 47-8. PubMed ID: 12599930
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.
De Marinis F; Bria E; Baas P; Tiseo M; Camerini A; Favaretto AG; Gridelli C
Clin Lung Cancer; 2015 Nov; 16(6):399-405. PubMed ID: 25989953
[TBL] [Abstract][Full Text] [Related]
32. Treatment of elderly patients with non-small-cell lung cancer.
Manegold C
Oncology (Williston Park); 2001 Mar; 15(3 Suppl 6):46-51. PubMed ID: 11301849
[TBL] [Abstract][Full Text] [Related]
33. Elderly patients with lung cancer: biases and evidence.
Langer CJ
Curr Treat Options Oncol; 2002 Feb; 3(1):85-102. PubMed ID: 12057091
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy options for the elderly patient with advanced non-small cell lung cancer.
Hennessy BT; Hanrahan EO; Breathnach OS
Oncologist; 2003; 8(3):270-7. PubMed ID: 12773749
[TBL] [Abstract][Full Text] [Related]
35. The Treatment of Advanced Lung Cancer in the Elderly: The Role of a Comprehensive Geriatric Assessment and Doublet Chemotherapy.
Presley C; Lilenbaum R
Cancer J; 2015; 21(5):392-7. PubMed ID: 26389764
[TBL] [Abstract][Full Text] [Related]
36. Treatment of lung cancer in the elderly patient.
Weiss J; Langer C
Semin Respir Crit Care Med; 2013 Dec; 34(6):802-9. PubMed ID: 24258570
[TBL] [Abstract][Full Text] [Related]
37. Role of chemotherapy in patients with poor performance status and advanced non-small cell lung cancer.
Langer C; Lilenbaum R
Semin Oncol; 2004 Dec; 31(6 Suppl 11):8-15. PubMed ID: 15599829
[TBL] [Abstract][Full Text] [Related]
38. Challenges associated with systemic therapy for older patients with inoperable non-small cell lung cancer.
O'Leary C; McSorley L; Hennessy B; Grogan L; Breathnach O; Morris P
Expert Opin Pharmacother; 2020 Dec; 21(17):2185-2194. PubMed ID: 32866411
[TBL] [Abstract][Full Text] [Related]
39. Influence of age and comorbidities on the chemotherapeutic management of lung cancer.
Deppermann KM
Lung Cancer; 2001 Sep; 33 Suppl 1():S115-20. PubMed ID: 11576716
[TBL] [Abstract][Full Text] [Related]
40. Elderly patients with advanced NSCLC: The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity.
Almodovar T; Teixeira E; Barroso A; Soares M; Queiroga HJ; Cavaco-Silva J; Barata F
Pulmonology; 2019; 25(1):40-50. PubMed ID: 30266308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
